Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle

Neuroscience Letters

Volumn 467, Issue 2, 2009, Pages 178-181

  Jiang, Lei ^a   Shi, Mingyi ^a   Guo, Lili ^a   He, Biao ^a   Li, Guangzhi ^a   Zhang, Ling ^a   Zhang, Lingxiang ^a   Shao, Hu ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Exercise; Galanin; GLUT4; Insulin; M35

Indexed keywords

GALANIN; GLUCOSE TRANSPORTER 4; INSULIN; M 35; OPIATE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; MUSCLE CELL; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SKELETAL MUSCLE; SWIMMING;

ANIMALS; BRADYKININ; CELL MEMBRANE; FEMALE; GALANIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; MUSCLE, SKELETAL; PEPTIDE FRAGMENTS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR;

EID: 70350574037     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.034     Document Type: Article

References (20)

1. Adeghate E., and Ponery A.S. Large reduction in the number of galanin-immunoreactive cells in pancreatic islerts of diabetic rats. Neuroendocrinology 8 (2001) 706-710
2. Ahren B., Pacini G., Wynick D., Wierup N., and Sundler F. Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 7 (2004) 3190-3196
3. Cheng H., Straub S.G., and Sharp G.W. Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, GAL and PGE2. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E287-E294
4. Farrell P.A., Caston A.L., and Rodd D. Changes in insulin response to glucose after exercise training in partially pancreatectomized rats. J. Appl. Physiol. 70 (1991) 1563-1568
5. Garcia-Roves P.M., Han D.H., Song Z., Jones T.E., Hucker K.A., and Holloszy J.O. Prevention of glycogen supercompensation prolongs the in the increase in muscle GLUT4 after exercise. Am. J. Physiol. 285 (2003) E729-E736
6. Geiger P.C., Han D.H., Wright D.C., and Holloszy J.O. How muscle insulin sensitivity is regulated: testing of a hypothesis. Am. J. Physiol. Endocrinol. Metab. 6 (2006) E1258-E1263
7. Hansen P.A., McCarthy T.J., Pasia E.N., Spina R.J., and Gulve E.A. Effects of ovariectomy and exercise training on muscle GLUT-4 content and glucose metabolism in rats. J. Appl. Physiol. 80 (1996) 1605-1611
8. Holmberg K., Kuteeva E., Brumovsky P., Kahl U., Karlström H., Lucas G.A., Rodriguez J., Westerblad H., Hilke S., Theodorsson E., Berge O.G., Lendah U., Bartfai T., and Hökfelt T. Generation and phenotypic characterization of a Galanin overexpressing mouse. Neuroscience 133 (2005) 59-77
9. Holmes P.V., Yoo H.S., and Dishman R.K. Voluntary exercise and clomipramine treatment elevate prepro-galanin mRNA levels in the locus coeruleus in rats. Neurosci. Lett. 1 (2006) 1-4
10. Kristiansen S., Ramlal T., and Klip A. Phosphatidylinositol 4-kinase, but not phosphatidylinositol 3-kinase, is present in GLUT4-containing vesicles isolated from rat skeletal muscle. Biochem. J. 335 (1998) 351-356
11. Lang R., Gundlach A.L., and Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2 (2007) 177-207
12. Legakis I.N., Mantzouridis T., and Mountokalakis T. Positive correlation of galanin with glucose in healthy volunteers during an oral glucose tolerance test. Horm. Metab. Res. 39 (2007) 53-55
13. Legakis I.N. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Drug News Perspect. 18 (2005) 173-177
14. Leibowitz S.F., Akabayashi A., Wang J., Alexander J.T., Dourmashrin J.T., and Chang G.Q. Increased caloric intake on a fat-rich diet: role of ovarian steroids and galanin in the medial preoptic and paraventricular nuclei and anterior pituitary of female rats. J. Neuroendocrinol. 10 (2007) 753-766
15. Milot M., and Trudeau F. Plasma galanin immunoreactivity in the rat after swimming. Physiol. Behav. 62 (1997) 697-700
16. Sweeney G., Keen J., Somwar R., Konrad D., Garg R., and Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in L6 rat skeletal muscle cells. Endocrinology 142 (2001) 4806-4812
17. Takács T., Hegyi P., Czakó L., Baláspiri L., and Lonovics J. Effects of galanin (1-16) on pancreatic secretion in anesthetized and conscious rats. Res. Exp. Med. 199 (2000) 275-283
18. Thien T.T., Neehar G., Tracy G., Dinaz N., Marie C.C., Niloofar K., Shruti M., Gail M.-E., Adria G., and Bruce W.R. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 47-56
19. Wang S., He C., Maguire M.T., Clemmons A.L., Burrier R.E., Guzzi M.F., Strader C.D., Parker E.M., and Bayne M.L. Genomic organization and functional characterization of the mouse GalR1 galanin receptor. FEBS Lett. 411 (1997) 225-230
20. Zdrojewiez Z., and Sowinska E. The significance of galanin in physiologic and pathologic processes in humans. Poste. Hig. Med. Dosw. 6 (2000) 819-833